Doximity Income Statement

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Year	2022	2021	2020	2019	2018
Revenue	419.05	343.55	206.9	116.39	85.7
Revenue Growth (YoY)	21.98%	66.05%	77.76%	35.82%	-
Cost of Revenue	53.49	39.79	31.2	14.9	10.89
Gross Profit	365.56	303.76	175.7	101.49	74.81
Selling, General & Admin	160.27	127.88	78.53	46.89	40.39
Research & Development	80.19	62.35	43.87	32.44	27.5
Operating Expenses	240.45	190.23	122.4	79.33	67.89
Operating Income	125.11	113.54	53.3	22.16	6.92
Other Expense / Income	-8.05	-0.47	-4.47	-1.35	-1.01
Pretax Income	133.16	114.01	57.77	23.51	7.93
Income Tax	20.34	-40.78	7.56	-6.22	0.1
Net Income	112.82	154.78	50.21	29.74	7.83
Preferred Dividends	0	21.53	28.65	18.91	7.24
Net Income Common	112.82	133.26	21.56	10.83	0.6
Net Income Growth	-15.34%	518.19%	99.06%	1720.00%	-
Shares Outstanding (Basic)	193	163	74	67	64
Shares Outstanding (Diluted)	213	191	95	82	76
Shares Change	11.73%	100.79%	16.43%	8.00%	-
EPS (Basic)	0.58	0.82	0.29	0.16	0.01
EPS (Diluted)	0.53	0.70	0.23	0.13	0.01
EPS Growth	-24.29%	204.35%	76.92%	1200.00%	-
Free Cash Flow	173.42	120.88	78.36	21.96	14.12
Free Cash Flow Per Share	0.90	0.74	1.05	0.33	0.22
Gross Margin	87.24%	88.42%	84.92%	87.20%	87.29%
Operating Margin	29.86%	33.05%	25.76%	19.04%	8.08%
Profit Margin	26.92%	38.79%	10.42%	9.30%	0.69%
Free Cash Flow Margin	41.38%	35.19%	37.88%	18.86%	16.47%
Effective Tax Rate	15.27%	-35.77%	13.08%	-26.47%	1.24%
EBITDA	145.47	120.2	63.9	26.41	8.48
EBITDA Margin	34.71%	34.99%	30.89%	22.69%	9.90%
Depreciation & Amortization	12.31	6.2	6.14	2.9	0.55
EBIT	133.16	114.01	57.77	23.51	7.93
EBIT Margin	31.78%	33.18%	27.92%	20.20%	9.25%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).